USE OF LAMBDA INTERFERONS IN THE TREATMENT OF OBESITY-RELATED DISORDERS AND RELATED DISEASES

摘要

The invention relates to the field of treatment or prevention of obesity-related disorders, atherosclerosis or a coagulation disorder. In particular, the present invention relates to the use of an activator of IFN» receptor for the treatment or prevention of such disorders or conditions, and corresponding methods of treatment.